missing translation for 'onlineSavingsMsg'
Learn More

CFI Monoclonal Antibody (OTI2D4), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA805858

Encompass_Preferred

 View more versions of this product

Product Code. 17555873

  • 540.87 EUR / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Factor I, a serine protease, is a regulatory component of both the alternative and the classical complement pathway. Factor I is synthesized as a single chain precursor of 88 kDa, processed to yield the acitve form, composed of two disulfide-linked chains, the a-chain (50 kDa) and the beta-chain (38 kDa). Plasma concentration is 35 ug/ml.
Specifications

Specifications

CFI
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
P05156
CFI
Human recombit protein fragment corresponding to amino acids 340-583 of human CFI produced in E.coli.
100 μL
Primary
Human
Antibody
IgG2a
Western Blot
OTI2D4
Unconjugated
CFI
AHUS3, ARMD13, C3BINA, C3b-INA, FI, IF, KAF
Mouse
Affinity Chromatography
RUO
3426
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.